The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...

Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance GSK reported core earnings of $1.09 per American depositary share (ADS) for second-quarter 2024, beating the Zacks Consensus Estimate of $1.00.

Less than two months after GlaxoSmithKline pledged to cap out-of-pocket costs, Sen. Maggie Hassan (D-N.H.) is accusing the company of circumventing that vow.

(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster ...

Earnings Estimate Revisions for Glaxo For the fiscal year ending December 2023, this drug developer is expected to earn $3.90 per share, which is a change of 12.7% from the year-ago reported number.

GlaxoSmithKline GSK announced that it had received three unsolicited, conditional and non-binding proposals from British multinational consumer goods company, Unilever UL for its Consumer business.

As we think about the sort of dynamics of making Glaxo, sorry. GSK, I just did a Wow. I'm going to have a lot of -- I'm going to have a lot of donations. That's fine. That's another, so I'm at 15 ...

Avandia: GlaxoSmithKline Cover-Up Turns Off Doctors GlaxoSmithKline withheld studies that made their drug Avandia, look unsafe. By ABC News July 13, 2010, 11:24 AM ...

Some GSK workers told they will become Novartis employees, according to source. GlaxoSmithKline’s mutlibillion-dollar deal with Novartis announced Tuesday morning is expected to impact the drug ...